Erika Hamilton: Masterful discussion of ILD with TDXd by Pat LoRusso
Erika Hamilton shared a post on X:
“Masterful discussion of ILD with TDXd by Dr. Pat LoRusso.
HER ‘low’ expression in lung – likely why worse with TDXd than other ADC targets.
Ethnicities such as Japanese at higher risk.
Prior ILD, hepatic and renal impairment all risk factors.”
Source: Erika Hamilton/X
More posts featuring Erika Hamilton on oncodaily.com
Erika Hamilton is a medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research Institute (USA). Dr. Hamilton is a past chair of ASCO’s Scientific Breast Committee ’21-’22, participant of the ASCO Leadership Development Program, Associate Editor for Clinical Breast Cancer, co-chair for Great Debates and Updates in Women’s Oncology Conference and a board member of the Susan G. Komen Foundation of Central Tennessee.
She is active in the community, volunteering with Gilda’s Club Middle Tennessee, the American Cancer Society’s Hope Lodge, Ovarcome ovarian cancer support organization, Brentwood Baptist Church and the Susan G. Komen Race for the Cure.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023